Article

Endocrinology News Quiz: Obesity and Osteoporosis

Author(s):

What's new in research on bisphosphonates, body-fat measurement, prebiotics, and insulin dosing? Find out with our quiz.

Are you up-to-date on the preferred antidiabetes agents for bone health? The optimal duration of bisphosphonate therapy? The effects of omega-3 supplements on diabetic neuropathy? Take this quick quiz and find out.

Note: If you would like more information on any of the questions, a link to the original article, “Interesting Endo: Obesity and Osteoporosis,” is provided on the last page of the quiz.

 

Question 1:

  

Click below for answer and next question.

 

The correct answer is C. Thiazolidinediones

 

Question 2.

Click below for answer and next question.

 

The correct answer is D. 10 to 13 years

 

Question 3.

Click below for answer and next question.

 

The correct answer is B. 6 years

 

Question 4.

Click below for answer and next question.

 

The correct answer is B. Caregiver body mass index

 

Question 5.

Click below for answer and next question.

 

The correct answer is A. Waist-to-height ratio

 

Question 6.

Click below for answer and next question.

 

 

The correct answer is C. Bifidobacterium species

 

Question 7.

Click below for answer and next question.

 

 

The correct answer is D. 12 months

 

Question 8.

Click below for answer and additional information.

 

The correct answer is A. True

For more information on all questions and answers, please visit “Interesting Endo: Obesity and Osteoporosis.”

Related Videos
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Rahul Aggarwal, MD | Credit: LinkedIn
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
Optimizing Diabetes Therapies with New Classifications
© 2024 MJH Life Sciences

All rights reserved.